Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02203903
Title Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)
Acronym RESOLVE
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Childrens National Medical Center RECRUITING Washington District of Columbia 20010 United States Details
Kenneth R. Cooke, MD RECRUITING Baltimore Maryland 21287 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field